Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding

Konstantinos Dean Boudoulas, Andrew Pederzolli, Uksha Saini, Richard J. Gumina, Ernest L. Mazzaferri, Michael Davis, Charles A. Bush, Quinn Capers IV, Raymond Magorien, Vincent J. Pompili

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: Compare vascular complications and incidence of bleeding of Impella 2.5 and intra-aortic balloon pump (IABP) in high-risk percutaneous coronary interventions (PCI). Background: Large arterial sheath size for device insertion is associated with vascular and/or bleeding complications; gastrointestinal bleeding may also occur with anti-coagulation use. Methods: Patients with an acute coronary syndrome receiving Impella 2.5 or IABP during high-risk PCI were studied (13 Impella; 62 IABP). Vascular complications and incidence of bleeding were compared. Results: Post-procedure hematocrit was similar between groups. Blood transfusion occurred in 38.4% and 32.2% of patients in the Impella and IABP groups, respectively (P = NS); 65.3%, 30.7% and 3.8% of bleeding were due to vascular access site/procedure related, gastrointestinal and genitourinary, respectively. There was no statistical significant difference in vascular complications between the Impella and IABP groups (15.3% and 6.4% of patients, respectively); mesenteric ischemia (n = 1) and aortic rupture (n = 1) were only in the IABP group. In-hospital and one-year mortality were not statistically significant between groups. Conclusion: Impella can be used as safely as IABP during high-risk PCI with similar vascular and bleeding complications. Importantly, approximately one third of bleeding was from the gastrointestinal system warranting careful prophylactic measures and monitoring.

Original languageEnglish (US)
Pages (from-to)120-124
Number of pages5
JournalAcute Cardiac Care
Volume14
Issue number4
DOIs
StatePublished - Dec 1 2012

Fingerprint

Percutaneous Coronary Intervention
Blood Vessels
Hemorrhage
Incidence
Aortic Rupture
Acute Coronary Syndrome
Hematocrit
Blood Transfusion
Equipment and Supplies
Mortality

Keywords

  • Impella
  • Intra-aortic balloon pump
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Emergency Medicine
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention : Vascular complications and incidence of bleeding. / Boudoulas, Konstantinos Dean; Pederzolli, Andrew; Saini, Uksha; Gumina, Richard J.; Mazzaferri, Ernest L.; Davis, Michael; Bush, Charles A.; Capers IV, Quinn; Magorien, Raymond; Pompili, Vincent J.

In: Acute Cardiac Care, Vol. 14, No. 4, 01.12.2012, p. 120-124.

Research output: Contribution to journalArticle

Boudoulas, KD, Pederzolli, A, Saini, U, Gumina, RJ, Mazzaferri, EL, Davis, M, Bush, CA, Capers IV, Q, Magorien, R & Pompili, VJ 2012, 'Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding', Acute Cardiac Care, vol. 14, no. 4, pp. 120-124. https://doi.org/10.3109/17482941.2012.741244
Boudoulas, Konstantinos Dean ; Pederzolli, Andrew ; Saini, Uksha ; Gumina, Richard J. ; Mazzaferri, Ernest L. ; Davis, Michael ; Bush, Charles A. ; Capers IV, Quinn ; Magorien, Raymond ; Pompili, Vincent J. / Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention : Vascular complications and incidence of bleeding. In: Acute Cardiac Care. 2012 ; Vol. 14, No. 4. pp. 120-124.
@article{76a0a5731bf34faf983efe05ad17a012,
title = "Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding",
abstract = "Objective: Compare vascular complications and incidence of bleeding of Impella 2.5 and intra-aortic balloon pump (IABP) in high-risk percutaneous coronary interventions (PCI). Background: Large arterial sheath size for device insertion is associated with vascular and/or bleeding complications; gastrointestinal bleeding may also occur with anti-coagulation use. Methods: Patients with an acute coronary syndrome receiving Impella 2.5 or IABP during high-risk PCI were studied (13 Impella; 62 IABP). Vascular complications and incidence of bleeding were compared. Results: Post-procedure hematocrit was similar between groups. Blood transfusion occurred in 38.4{\%} and 32.2{\%} of patients in the Impella and IABP groups, respectively (P = NS); 65.3{\%}, 30.7{\%} and 3.8{\%} of bleeding were due to vascular access site/procedure related, gastrointestinal and genitourinary, respectively. There was no statistical significant difference in vascular complications between the Impella and IABP groups (15.3{\%} and 6.4{\%} of patients, respectively); mesenteric ischemia (n = 1) and aortic rupture (n = 1) were only in the IABP group. In-hospital and one-year mortality were not statistically significant between groups. Conclusion: Impella can be used as safely as IABP during high-risk PCI with similar vascular and bleeding complications. Importantly, approximately one third of bleeding was from the gastrointestinal system warranting careful prophylactic measures and monitoring.",
keywords = "Impella, Intra-aortic balloon pump, Percutaneous coronary intervention",
author = "Boudoulas, {Konstantinos Dean} and Andrew Pederzolli and Uksha Saini and Gumina, {Richard J.} and Mazzaferri, {Ernest L.} and Michael Davis and Bush, {Charles A.} and {Capers IV}, Quinn and Raymond Magorien and Pompili, {Vincent J.}",
year = "2012",
month = "12",
day = "1",
doi = "10.3109/17482941.2012.741244",
language = "English (US)",
volume = "14",
pages = "120--124",
journal = "Acute Cardiac Care",
issn = "1748-2941",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention

T2 - Vascular complications and incidence of bleeding

AU - Boudoulas, Konstantinos Dean

AU - Pederzolli, Andrew

AU - Saini, Uksha

AU - Gumina, Richard J.

AU - Mazzaferri, Ernest L.

AU - Davis, Michael

AU - Bush, Charles A.

AU - Capers IV, Quinn

AU - Magorien, Raymond

AU - Pompili, Vincent J.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Objective: Compare vascular complications and incidence of bleeding of Impella 2.5 and intra-aortic balloon pump (IABP) in high-risk percutaneous coronary interventions (PCI). Background: Large arterial sheath size for device insertion is associated with vascular and/or bleeding complications; gastrointestinal bleeding may also occur with anti-coagulation use. Methods: Patients with an acute coronary syndrome receiving Impella 2.5 or IABP during high-risk PCI were studied (13 Impella; 62 IABP). Vascular complications and incidence of bleeding were compared. Results: Post-procedure hematocrit was similar between groups. Blood transfusion occurred in 38.4% and 32.2% of patients in the Impella and IABP groups, respectively (P = NS); 65.3%, 30.7% and 3.8% of bleeding were due to vascular access site/procedure related, gastrointestinal and genitourinary, respectively. There was no statistical significant difference in vascular complications between the Impella and IABP groups (15.3% and 6.4% of patients, respectively); mesenteric ischemia (n = 1) and aortic rupture (n = 1) were only in the IABP group. In-hospital and one-year mortality were not statistically significant between groups. Conclusion: Impella can be used as safely as IABP during high-risk PCI with similar vascular and bleeding complications. Importantly, approximately one third of bleeding was from the gastrointestinal system warranting careful prophylactic measures and monitoring.

AB - Objective: Compare vascular complications and incidence of bleeding of Impella 2.5 and intra-aortic balloon pump (IABP) in high-risk percutaneous coronary interventions (PCI). Background: Large arterial sheath size for device insertion is associated with vascular and/or bleeding complications; gastrointestinal bleeding may also occur with anti-coagulation use. Methods: Patients with an acute coronary syndrome receiving Impella 2.5 or IABP during high-risk PCI were studied (13 Impella; 62 IABP). Vascular complications and incidence of bleeding were compared. Results: Post-procedure hematocrit was similar between groups. Blood transfusion occurred in 38.4% and 32.2% of patients in the Impella and IABP groups, respectively (P = NS); 65.3%, 30.7% and 3.8% of bleeding were due to vascular access site/procedure related, gastrointestinal and genitourinary, respectively. There was no statistical significant difference in vascular complications between the Impella and IABP groups (15.3% and 6.4% of patients, respectively); mesenteric ischemia (n = 1) and aortic rupture (n = 1) were only in the IABP group. In-hospital and one-year mortality were not statistically significant between groups. Conclusion: Impella can be used as safely as IABP during high-risk PCI with similar vascular and bleeding complications. Importantly, approximately one third of bleeding was from the gastrointestinal system warranting careful prophylactic measures and monitoring.

KW - Impella

KW - Intra-aortic balloon pump

KW - Percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=84870947036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870947036&partnerID=8YFLogxK

U2 - 10.3109/17482941.2012.741244

DO - 10.3109/17482941.2012.741244

M3 - Article

C2 - 23215746

AN - SCOPUS:84870947036

VL - 14

SP - 120

EP - 124

JO - Acute Cardiac Care

JF - Acute Cardiac Care

SN - 1748-2941

IS - 4

ER -